Mark Keigwin leads supply chain systems at Vertex Pharmaceuticals, a company that has fundamentally changed what it means to treat cystic fibrosis and is now extending that scientific ambition to other serious genetic diseases.
As Associate Director of Supply Chain Systems, he is responsible for the digital infrastructure that underpins the supply chain. This includes planning tools, data platforms, and process architectures that enable operational intelligence at scale.
In pharmaceutical supply chains, systems are not a background function. They determine how well materials can be traced across a complex global network, how disruptions are anticipated and managed, and how inventory decisions are made in ways that reduce waste without compromising availability.
Mark’s role sits directly at this intersection. The quality of the systems he manages shapes how effectively the supply chain can respond to both operational and sustainability demands.
His work also connects to Vertex’s broader commitments to responsible business. In an industry where regulatory compliance and patient safety introduce additional layers of complexity, the systems layer becomes even more critical.
Mark brings a perspective shaped by working in this high-stakes environment—where operational precision, transparency, and reliability are not optional, but foundational.
Found them interesting? Connect with Mark on LinkedIn.
